Forte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update
15.08.2022 - Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune diseases, today announced second quarter 2022 results and provided a business update. “Forte is excited to continue down our new path as ...
Steve Doberstein Hubert Chen Exchange Commission Exchange Commission On Nektar Therapeutics Forte Biosciences Inc
Source: wallstreet-online.de